These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25817855)

  • 1. Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders.
    Ohgi Y; Futamura T; Hashimoto K
    Curr Mol Med; 2015; 15(3):206-21. PubMed ID: 25817855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of glutamate on the action of antidepressants.
    Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1558-68. PubMed ID: 20600468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptors in the control of mood disorders.
    Witkin JM; Marek GJ; Johnson BG; Schoepp DD
    CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):87-100. PubMed ID: 17430147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function.
    Duman RS; Shinohara R; Fogaça MV; Hare B
    Mol Psychiatry; 2019 Dec; 24(12):1816-1832. PubMed ID: 30894661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptors as therapeutic targets for depression treatment: Evidence from clinical to basic research.
    Lv S; Yao K; Zhang Y; Zhu S
    Neuropharmacology; 2023 Mar; 225():109378. PubMed ID: 36539011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors.
    Musazzi L; Treccani G; Mallei A; Popoli M
    Biol Psychiatry; 2013 Jun; 73(12):1180-8. PubMed ID: 23273725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of NMDA receptors in the treatment of major depression.
    Dang YH; Ma XC; Zhang JC; Ren Q; Wu J; Gao CG; Hashimoto K
    Curr Pharm Des; 2014; 20(32):5151-9. PubMed ID: 24410564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-methyl-D-aspartate receptor antagonist CPP alters synapse and spine structure and impairs long-term potentiation and long-term depression induced morphological plasticity in dentate gyrus of the awake rat.
    Medvedev NI; Popov VI; Rodriguez Arellano JJ; Dallérac G; Davies HA; Gabbott PL; Laroche S; Kraev IV; Doyère V; Stewart MG
    Neuroscience; 2010 Feb; 165(4):1170-81. PubMed ID: 19961908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of Coordinated Presynaptic and Postsynaptic Maturation Underlies the Defects in Hippocampal Synapse Stability and Plasticity in Abl2/Arg-Deficient Mice.
    Xiao X; Levy AD; Rosenberg BJ; Higley MJ; Koleske AJ
    J Neurosci; 2016 Jun; 36(25):6778-91. PubMed ID: 27335408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
    Kavalali ET; Monteggia LM
    Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.
    Licznerski P; Duman RS
    Neuroscience; 2013 Oct; 251():33-50. PubMed ID: 23036622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
    Miller OH; Moran JT; Hall BJ
    Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of glutamate in the pathophysiology of major depressive disorder.
    Hashimoto K
    Brain Res Rev; 2009 Oct; 61(2):105-23. PubMed ID: 19481572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the Role of Glutamate in Presynaptic Development: Possible Contributions of Presynaptic NMDA Receptors.
    Fedder KN; Sabo SL
    Biomolecules; 2015 Dec; 5(4):3448-66. PubMed ID: 26694480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research.
    Amidfar M; Woelfer M; Réus GZ; Quevedo J; Walter M; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109668. PubMed ID: 31207274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review.
    Petrie RX; Reid IC; Stewart CA
    Pharmacol Ther; 2000 Jul; 87(1):11-25. PubMed ID: 10924739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Group II Metabotropic Glutamate Receptors Promotes LTP Induction at Schaffer Collateral-CA1 Pyramidal Cell Synapses by Priming NMDA Receptors.
    Rosenberg N; Gerber U; Ster J
    J Neurosci; 2016 Nov; 36(45):11521-11531. PubMed ID: 27911756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depression.
    Serafini G; Pompili M; Innamorati M; Dwivedi Y; Brahmachari G; Girardi P
    Curr Pharm Des; 2013; 19(10):1898-922. PubMed ID: 23173582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (
    Shafique H; Demers JC; Biesiada J; Golani LK; Cerne R; Smith JL; Szostak M; Witkin JM
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.